Published in Am J Rhinol on December 23, 1999
Histamine receptors that influence blockage of the normal human nasal airway. Br J Pharmacol (2005) 0.91
Roles of histamine and its receptors in allergic and inflammatory bowel diseases. World J Gastroenterol (2005) 0.89
Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors. Br J Pharmacol (2011) 0.88
Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol (2014) 0.85
Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines. J Asthma Allergy (2009) 0.75
Multiple Targeting Approaches on Histamine H3 Receptor Antagonists. Front Neurosci (2016) 0.75
Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem (1995) 2.95
Prostaglandins, arachidonic acid, and inflammation. Science (1980) 2.55
Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem (1976) 2.30
Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. J Biol Chem (1988) 1.89
Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature (1977) 1.89
Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis (1993) 1.73
IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol (1994) 1.66
Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol (1994) 1.66
Regulation of phospholipase D in HL-60 granulocytes. Activation by phorbol esters, diglyceride, and calcium ionophore via protein kinase- independent mechanisms. J Biol Chem (1989) 1.65
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy (2001) 1.63
Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay. J Immunol (1983) 1.53
Role of CXCR2 in cigarette smoke-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol (2005) 1.49
Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med (1995) 1.40
Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res (2001) 1.38
Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes. Biochem Biophys Res Commun (1988) 1.34
Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol (1995) 1.32
Peroxidase-dependent deactivation of prostacyclin synthetase. J Biol Chem (1979) 1.26
Existence of cytosolic phospholipase D. Identification and comparison with membrane-bound enzyme. J Biol Chem (1991) 1.25
Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol (1999) 1.24
Antitussive effects of GABAB agonists in the cat and guinea-pig. Br J Pharmacol (1993) 1.22
Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood (1994) 1.22
Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes. Arzneimittelforschung (1996) 1.22
Influence of central antitussive drugs on the cough motor pattern. J Appl Physiol (1985) (1999) 1.21
T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol (1995) 1.20
Capsaicin exposure elicits complex airway defensive motor patterns in normal humans in a concentration-dependent manner. Pulm Pharmacol Ther (2006) 1.18
Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol (1995) 1.18
A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcription. Am J Respir Cell Mol Biol (2001) 1.17
Tachykinin NK3-receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice. Pharmacol Res (2004) 1.17
Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol (2001) 1.16
Phospholipase D in homogenates from HL-60 granulocytes: implications of calcium and G protein control. Biochem Biophys Res Commun (1989) 1.12
Dependence on insulin of the apparent hydrocortisone activation of hepatic glycogen synthetase. Proc Natl Acad Sci U S A (1967) 1.12
Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig. Br J Pharmacol (1994) 1.11
Prejunctional GABA-B inhibition of cholinergic, neurally-mediated airway contractions in guinea-pigs. Pulm Pharmacol (1991) 1.10
Identification of two H3-histamine receptor subtypes. Mol Pharmacol (1990) 1.08
Modulation of cardiovascular function by central histamine H3 receptors in conscious guinea pigs. Eur J Pharmacol (1991) 1.07
Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Arzneimittelforschung (1996) 1.06
Leukotriene C4 binding to rat lung membranes. J Biol Chem (1983) 1.06
Biologically active derivatives of fatty acids: prostaglandins, thromboxanes, and endoperoxides. Inflammation (1977) 1.06
GABAB receptors in the lung. Trends Pharmacol Sci (1993) 1.04
Identification of transcription factor binding sites important in the regulation of the human interleukin-5 gene. J Biol Chem (1997) 1.04
Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol (1997) 1.04
Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis (1992) 1.03
Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat. Br J Pharmacol (1997) 0.99
Hydrophile-lipophile balance and critical micelle concentration as key factors influencing surfactant disruption of mitochondrial membranes. J Biol Chem (1976) 0.98
Reduction of hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase. J Biol Chem (1979) 0.98
Characterization and tissue distribution of H3 histamine receptors in guinea pigs by N alpha-methylhistamine. Biochem Biophys Res Commun (1990) 0.97
Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity. Arzneimittelforschung (1999) 0.97
Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol (1999) 0.97
Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes. Mol Pharmacol (1999) 0.96
The role of IL-5 in bleomycin-induced pulmonary fibrosis. J Leukoc Biol (1998) 0.96
Oxidation reactions by prostaglandin cyclooxygenase-hydroperoxidase. J Biol Chem (1981) 0.94
Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittelforschung (2000) 0.94
Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution. Gene (2001) 0.93
Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. Am J Respir Crit Care Med (1998) 0.93
Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors. Br J Pharmacol (2001) 0.92
Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides. J Immunol (1990) 0.92
The profiles of human and primate [3H]Nalpha-methylhistamine binding differ from that of rodents. Eur J Pharmacol (1999) 0.92
Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines. Br J Pharmacol (2000) 0.91
Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells. J Leukoc Biol (2000) 0.91
Antitussive action of nociceptin in the cat. Eur J Pharmacol (2001) 0.91
Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Agents Actions (1984) 0.90
Granulocyte phospholipase D is activated by a guanine nucleotide dependent protein factor. Biochem Biophys Res Commun (1991) 0.90
Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea pigs. Modulation by betamethasone, phenidone, indomethacin, WEB 2086, and a novel antiallergy agent, SCH 37224. Am Rev Respir Dis (1990) 0.90
Biexponential kinetics of (R)-alpha-[3H]methylhistamine binding to the rat brain H3 histamine receptor. J Neurochem (1990) 0.90
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist. J Pharmacol Exp Ther (1995) 0.89
Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun (1997) 0.89
Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol (1998) 0.89
Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma. Am J Respir Cell Mol Biol (1998) 0.88
Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung. Eur J Pharmacol (2000) 0.88
Inhibition of mammalian 5-lipoxygenase by aromatic disulfides. J Biol Chem (1985) 0.88
Direct and indirect involvement of radical scavengers during prostaglandin biosynthesis. Adv Prostaglandin Thromboxane Res (1980) 0.88
Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol (1994) 0.88
A novel pyrrolidine analog of histamine as a potent, highly selective histamine H3 receptor agonist. J Med Chem (1995) 0.88
Antitussive action of antihistamines is independent of sedative and ventilation activity in the guinea pig. Pharmacology (1998) 0.87
Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases. Life Sci (2001) 0.87
Pharmacological studies of allergic cough in the guinea pig. Eur J Pharmacol (1995) 0.87